Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at adding radiotherapy to atezolizumab for people with urothelial (urinary tract) cancer that has spread (RE-ARM)

Overview

Cancer types:

Bladder cancer, Kidney cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with urothelial (urinary tract) cancer that has spread to somewhere else in the body.

It is looking at adding radiotherapy to a drug called atezolizumab. The team want to find out if it works better than ateolizumab on its own.

Cancer Research UK supports this trial.

Recruitment start: 15 September 2021

Recruitment end: 8 February 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Robert Huddart

Supported by

Cancer Research UK

Institute of Cancer Research (ICR)

National Institute for Health Research (NIHR)

Roche

Other information

This is Cancer Research UK trial number CRUKE/19/009.

Last reviewed: 6 March 2024

CRUK internal database number: 17241

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.